EA201390327A1 - Гетероциклильные соединения в качестве лигандов гистаминовых hрецепторов - Google Patents

Гетероциклильные соединения в качестве лигандов гистаминовых hрецепторов

Info

Publication number
EA201390327A1
EA201390327A1 EA201390327A EA201390327A EA201390327A1 EA 201390327 A1 EA201390327 A1 EA 201390327A1 EA 201390327 A EA201390327 A EA 201390327A EA 201390327 A EA201390327 A EA 201390327A EA 201390327 A1 EA201390327 A1 EA 201390327A1
Authority
EA
Eurasian Patent Office
Prior art keywords
histomine
hepathogen
compounds
receptor ligands
heterocyclyl compounds
Prior art date
Application number
EA201390327A
Other languages
English (en)
Other versions
EA022746B1 (ru
Inventor
Рамакришна Нироджи
Анил Карбхари Схинде
Рамасастри Камбхампати
Рамбабу Намала
Ади Редди Дварампуди
Лаксман Кота
Мурлимохан Гампа
Падмаватхи Кодру
Тарака Нага Винаикумар Тиривеедхи
Вишвоттам Нагарадж Кандикере
Нагешвара Рао Муддана
Раманатха Шрикантха Саралая
Прадееп Джаяраджан
Дханалакшми Шанмуганатхан
Иштияки Ахмад
Венкатесварлу Джасти
Original Assignee
Сувен Лайф Сайенсиз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сувен Лайф Сайенсиз Лимитед filed Critical Сувен Лайф Сайенсиз Лимитед
Publication of EA201390327A1 publication Critical patent/EA201390327A1/ru
Publication of EA022746B1 publication Critical patent/EA022746B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Abstract

Настоящее изобретение относится к гетероциклильным соединениям формулы (I) и их фармацевтически приемлемым солям и к композициям, содержащим такие соединения.Настоящее изобретение также относится к способу получения указанных выше новых соединений и их фармацевтически приемлемых солей. Соединения формулы (I) являются полезными в лечения различных расстройств, которые связаны с гистаминовыми Нрецепторами.
EA201390327A 2010-09-02 2010-11-15 Гетероциклические соединения в качестве лигандов гистаминовых hрецепторов EA022746B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2551CH2010 2010-09-02
PCT/IN2010/000740 WO2012029070A1 (en) 2010-09-02 2010-11-15 Heterocyclyl compounds as histamine h3 receptor ligands

Publications (2)

Publication Number Publication Date
EA201390327A1 true EA201390327A1 (ru) 2013-08-30
EA022746B1 EA022746B1 (ru) 2016-02-29

Family

ID=43608695

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201390327A EA022746B1 (ru) 2010-09-02 2010-11-15 Гетероциклические соединения в качестве лигандов гистаминовых hрецепторов

Country Status (27)

Country Link
US (1) US8912179B2 (ru)
EP (1) EP2611444B1 (ru)
JP (1) JP5650329B2 (ru)
KR (1) KR101538239B1 (ru)
CN (1) CN103079566B (ru)
AU (1) AU2010360038B2 (ru)
BR (1) BR112013005084A2 (ru)
CA (1) CA2812970C (ru)
CY (1) CY1117096T1 (ru)
DK (1) DK2611444T3 (ru)
EA (1) EA022746B1 (ru)
ES (1) ES2558531T3 (ru)
HK (1) HK1180955A1 (ru)
HR (1) HRP20151380T1 (ru)
HU (1) HUE028435T2 (ru)
IL (1) IL224652A (ru)
ME (1) ME02320B (ru)
MX (1) MX354852B (ru)
NZ (1) NZ607658A (ru)
PL (1) PL2611444T3 (ru)
PT (1) PT2611444E (ru)
RS (1) RS54514B1 (ru)
SG (1) SG188212A1 (ru)
SI (1) SI2611444T1 (ru)
SM (1) SMT201600012B (ru)
WO (1) WO2012029070A1 (ru)
ZA (1) ZA201301143B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2878217C (en) * 2012-08-23 2016-05-17 Suven Life Sciences Limited Acrylamide compounds as histamine h3 receptor ligands
CN104530088A (zh) * 2014-12-08 2015-04-22 苏州施亚生物科技有限公司 2-氨基-6,7-二氢-5H-噻唑并[5,4-b]吡啶-4-羧酸叔丁酯及其衍生物,以及它们的合成方法
EP3378477A1 (en) * 2017-03-21 2018-09-26 BIOPROJET Pharma New therapeutical use of h3-ligands
KR20200083551A (ko) 2017-11-02 2020-07-08 아이쿠리스 게엠베하 운트 코. 카게 B형 간염 바이러스 (hbv)에 활성인 신규 고활성 아미노-티아졸 치환된 인돌-2-카르복스아미드

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695575A (en) 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
PH23995A (en) 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
DE60234453D1 (de) 2001-07-02 2009-12-31 High Point Pharmaceuticals Llc Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
RU2005106274A (ru) 2002-09-06 2005-11-10 Янссен Фармацевтика, Н.В. (Be) Гетероциклические соединения
CN101018769A (zh) * 2004-07-16 2007-08-15 詹森药业有限公司 二聚哌啶衍生物
MX2007000616A (es) * 2004-07-16 2007-03-07 Janssen Pharmaceutica Nv Derivados dimericos de piperidina.
CA2601644A1 (en) * 2005-03-14 2006-09-21 Glaxo Group Limited Fused thiazole derivatives having affinity for the histamine h3 receptor
EP1999120B1 (en) * 2006-03-28 2012-06-27 High Point Pharmaceuticals, LLC Benzothiazoles having histamine h3 receptor activity
EP2049548A1 (en) * 2006-07-27 2009-04-22 UCB Pharma, S.A. Fused oxazoles & thiazoles as histamine h3- receptor ligands
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US7557101B2 (en) * 2006-12-08 2009-07-07 Hoffman-La Roche Inc. 4,5,6,7-tetrahydro-thieno[3,2-c] pyridine derivatives
US20080146559A1 (en) * 2006-12-08 2008-06-19 Li Chen 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives
US20100292188A1 (en) * 2008-01-24 2010-11-18 Ucb Pharma S.A. Compounds Comprising A Cyclobutoxy Group
WO2010026113A1 (en) 2008-09-03 2010-03-11 Evotec Neurosciences Gmbh Acyl- and sufonyl tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists

Also Published As

Publication number Publication date
MX354852B (es) 2018-03-22
RS54514B1 (en) 2016-06-30
HK1180955A1 (en) 2013-11-01
ME02320B (me) 2016-06-20
CY1117096T1 (el) 2017-04-05
BR112013005084A2 (pt) 2020-08-25
PT2611444E (pt) 2016-02-04
CA2812970C (en) 2015-01-13
EA022746B1 (ru) 2016-02-29
US20140148440A1 (en) 2014-05-29
EP2611444B1 (en) 2015-10-14
CA2812970A1 (en) 2012-03-08
DK2611444T3 (en) 2016-01-11
CN103079566B (zh) 2015-06-17
HUE028435T2 (en) 2016-12-28
SMT201600012B (it) 2016-02-25
KR101538239B1 (ko) 2015-07-20
PL2611444T3 (pl) 2016-03-31
AU2010360038A1 (en) 2013-04-04
JP5650329B2 (ja) 2015-01-07
IL224652A (en) 2016-05-31
KR20130042605A (ko) 2013-04-26
SI2611444T1 (sl) 2016-04-29
ES2558531T3 (es) 2016-02-05
AU2010360038B2 (en) 2014-05-15
MX2013001988A (es) 2013-05-09
WO2012029070A1 (en) 2012-03-08
SG188212A1 (en) 2013-04-30
JP2013536834A (ja) 2013-09-26
ZA201301143B (en) 2013-10-30
US8912179B2 (en) 2014-12-16
EP2611444A1 (en) 2013-07-10
CN103079566A (zh) 2013-05-01
HRP20151380T1 (hr) 2016-01-15
NZ607658A (en) 2014-02-28

Similar Documents

Publication Publication Date Title
EA201491672A1 (ru) Гетероциклильные соединения как ингибиторы mek
EA201391056A1 (ru) Гетероарильные соединения в качестве лигандов 5-htрецептора
EA201391615A1 (ru) Дейтерированные потенциаторы cftr
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
EA201390381A1 (ru) Триазиноксадиазолы
EA201590879A1 (ru) Арилконденсированные и гетероарилконденсированные лактамы
PH12015500376B1 (en) Novel bicyclic pyridinones
EA201391211A1 (ru) Новые соединения в качестве лигандов гистаминовых h-рецепторов
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
EA201301181A1 (ru) Триазолопиридины
EA201590228A1 (ru) Антагонисты 5-ht3 рецептора
EA201590735A1 (ru) 2-фенил-5-гетероциклил-тетрагидро-2h-пиран-3-аминовые соединения для применения в лечении диабета и связанных с ним расстройств
EA201590183A1 (ru) Производные азаиндола, выступающие в качестве ингибиторов pi3k
PH12014501195A1 (en) Novel 2h-indazoles as ep2, receptor antagonists
EA201391797A1 (ru) 3-спироциклические пиперидиновые производные в качестве агонистов грелиновых рецепторов
EA201792594A1 (ru) Положительные аллостерические модуляторы мусаринового рецептора м1
EA201790830A1 (ru) Ингибиторы альдостеронсинтазы
EA201791829A1 (ru) Амидные соединения в качестве агонистов рецептора 5-ht
EA201390327A1 (ru) Гетероциклильные соединения в качестве лигандов гистаминовых hрецепторов
MX2015012600A (es) Compuestos de tetrahidroisoquinolina-2-il-(quinazolina-4-il) metanona como inhibidores del crecimiento de células cancerígenas.
EA201491878A8 (ru) Замещенные ксантиновые производные
WO2013048949A3 (en) Selective nr2b antagonists
MY162945A (en) Azole derivative
EA201590413A1 (ru) Соединения акриламида в качестве лигандов h-рецептора гистамина
EA201691252A1 (ru) Соединения индазола в качестве агонистов 5-ht-рецептора

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU